Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International Journal of Developmental Neuroscience

• Publication date

  1999-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0736-5748(99)00053-2PMID 10571419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene therapy for brain tumors

  2000cited by this paper
• Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis.

  1998cited by this paper
• Pathology and Genetics of Tumours of the Nervous System

  1998cited by this paper
• Gene therapy of malignant glioma: recent advances in experimental and clinical studies.

  1998cited by this paper
• Gene therapy strategies for tumor antiangiogenesis.

  1998cited by this paper
• Halting angiogenesis suppresses carcinoma cell invasion

  1997cited by this paper
• Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

  1997cited by this paper
• Gene therapy of malignant glioma via inhibition of tumor angiogenesis

  1996cited by this paper
• Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.

  1996cited by this paper
• Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.

  1996cited by this paper
• Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.

  1996cited by this paper
• Flk-1 as a target for tumor growth inhibition.

  1996cited by this paper
• Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.

  1995cited by this paper
• Angiogenesis in malignant gliomas

  1995cited by this paper
• Gene Therapy for Brain Tumors

  1995cited by this paper
• Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible In vivo regulatory mechanisms

  1994cited by this paper
• Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

  1994cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.

  1993cited by this paper
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

  1993cited by this paper
• High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

  1993cited by this paper
• Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

  1992cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo

  1992cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

  1992cited by this paper
• Experimental therapy of human glioma by means of a genetically engineered virus mutant

  1991cited by this paper
• Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions

  1991cited by this paper
• What is the evidence that tumors are angiogenesis dependent?

  1990cited by this paper
• Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

  1989cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Vascular permeability factor, an endothelial cell mitogen related to PDGF.

  1989cited by this paper
• A safe packaging line for gene transfer: separating viral genes on two different plasmids

  1988cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987cited by this paper

• 2005-0101 Gene Therapy and Targeted Toxins for Glioma

  2019cites this paper
• Kobe University Repository : Kernel specific kinase inhibitor inhibited the growth of GS-9L glioma in rat brain and prolonged the survival

  2017cites this paper
• Special Techniques in Toxicologic Pathology

  2013cites this paper
• Angiogenesis in Brain Tumors

  2013cites this paper
• Future Prospects and Challenges of Antiangiogenic Cancer Gene Therapy

  2010cites this paper
• Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.

  2010cites this paper
• Brain Tumor Therapy with Antisense Oligonucleotides

  2009cites this paper
• Angiogenesis in Gliomas Marcia Machein and Lourdes Sánchez de Miguel 12

  2009cites this paper
• Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy

  2009cites this paper
• Angiogenesis in gliomas.

  2009cites this paper
• 1 Brain Tumor Angiogenesis

  2009cites this paper
• Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors

  2009cites this paper
• Antiangiogenic Therapy for Primary CNS Tumors

  2008cites this paper
• Angiogenesis and Anti-Angiogenesis in Brain Tumors

  2007cites this paper
• Inhibition of Vascular Endothelial Growth Factor (VEGF)-A Causes a Paradoxical Increase in Tumor Blood Flow and Up-Regulation of VEGF-D

  2006cites this paper
• Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27

  2006cites this paper
• Novel Gene Therapeutic Approaches to Brain Cancer

  2006cites this paper
• Anti-angiogenic Therapy in Pediatric Neuro-oncology

  2005cites this paper
• Angiogenesis in Gliomas: Imaging and Experimental Therapeutics

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• Inhibiting Cancer Angiogenesis With Molecular Therapy

  2005cites this paper
• [Angiogenesis and anti-angiogenic strategies for glioblastoma].

  2005cites this paper
• Difference in Risk of Cerebral Aneurysm Recurrence after Surgical Treatment between Ruptured and Unruptured Patients: 800

  2004cites this paper
• PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.

  2004cites this paper
• Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo.

  2004cites this paper
• Anti-angiogenic chemotherapy in central nervous system tumors.

  2004cites this paper
• Inhibition of Glioma Angiogenesis and Invasion by SI-27, an Anti-Matrix Metalloproteinase Agent in a Rat Brain Tumor Model

  2004cites this paper
• Minor Contribution of Bone Marrow‐Derived Endothelial Progenitors to the Vascularization of Murine Gliomas

  2003cites this paper
• Gene Therapy with Virus Vectors for specific Disease of the Nervous System: Recombinant Retrovirus Vectors for Treatment of Malignant Brain Tumors

  2003cites this paper
• Anti-invasive Effect of an Anti-Matrix Metalloproteinase Agent in a Murine Brain Slice Model Using the Serial Monitoring of Green Fluorescent Protein-labeled Glioma Cells

  2003cites this paper
• Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA.

  2002cites this paper
• Anti-angiogenic agents for the treatment of brain tumors.

  2002cites this paper
• Retroviral gene transfer of interferon‐inducible protein 10 inhibits growth of human melanoma xenografts

  2002cites this paper
• Inhibition of glioma growth by tumor-specific activation of double-stranded RNA–dependent protein kinase PKR

  2002cites this paper
• SI-27, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity: Detection with a Variable-pressure Scanning Electron Microscope

  2002cites this paper
• FLUORESCENT PROTEIN-LABELED GLIOMA CELLS

  2002cites this paper
• Flk-1 specific kinase inhibitor (SU5416) inhibited the growth of GS-9L glioma in rat brain and prolonged the survival.

  2001cites this paper
• Targeting tumor angiogenesis with gene therapy.

  2001cites this paper
• Gene therapy of glioblastomas: from suicide to homicide.

  2001cites this paper
• Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma.

  2001cites this paper
• Commentary: Gene Therapy for Glioblastoma: Future Perspective for Delivery Systems and Molecular Targets

  2001cites this paper
• Potential of gene therapy for brain tumors.

  2001cites this paper
• Antiangiogenic Gene Therapy in Cancer.

  2000cites this paper
• Vascular Endothelial Growth Factor-driven Glioma Growth and Vascularization in an Orthotopic Rat Model Monitored by Magnetic Resonance Imaging

  2000cites this paper
• Gene therapy for brain tumors

  2000cites this paper
• Anti-angiogenic Treatment Strategies for Malignant Brain Tumors

  2000cites this paper
• Genes that Regulate Metastasis and Angiogenesis

  2000cites this paper
• ARROW@TU Dublin ARROW@TU Dublin

  year unknowncites this paper
• Dokumentation Und Evaluation Der Weiterbildung Review Article · Übersichtsarbeit Therapeutic Anti-angiogenesis for Malignant Brain Tumors

  year unknowncites this paper